CAS 28523-86-6
:Sevoflurane
Description:
Sevoflurane is a volatile anesthetic agent commonly used in medical settings for induction and maintenance of general anesthesia. It is characterized by its low blood-gas partition coefficient, which allows for rapid onset and recovery, making it particularly advantageous in outpatient surgical procedures. Sevoflurane is a colorless, non-flammable liquid at room temperature and has a pleasant, sweet odor, which contributes to its ease of use in clinical practice. Its molecular formula is C4H3F7O, and it belongs to the class of halogenated ethers. The substance is metabolized primarily in the liver, with minimal production of toxic metabolites, making it relatively safe for patients. Sevoflurane is also known for its cardiovascular stability, as it tends to maintain hemodynamic parameters during anesthesia. However, it is important to monitor for potential side effects, such as respiratory depression and the risk of nephrotoxicity in certain populations. Overall, sevoflurane is a widely utilized anesthetic due to its favorable pharmacokinetic and pharmacodynamic properties.
Formula:C4H3F7O
InChI:InChI=1S/C4H3F7O/c5-1-12-2(3(6,7)8)4(9,10)11/h2H,1H2
InChI key:InChIKey=DFEYYRMXOJXZRJ-UHFFFAOYSA-N
SMILES:C(C(F)(F)F)(C(F)(F)F)OCF
Synonyms:- 1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane
- 347mmzEβγ
- Ether, fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl
- Fluoromethyl 1,1,1,3,3,3-hexafluoro-2-propyl ether
- Fluoromethyl 1,1,1,3,3,3-hexafluoroisopropyl ether
- Fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
- Mr 6S4
- R-E 347
- Sevocris
- Sevoflo
- Sevofluran
- Sevoflurane
- Sevofrane
- Sevohale
- Sevorane
- Ultane
- Fluoromethyl 1,1,1,3,3,3-hexafluoropropan-2-yl ether
- 1,1,1,3,3,3-Hexafluor-2-(fluormethoxy)propan
- oxyde de fluorométhyle et de 2,2,2-trifluoro-1-(trifluorométhyl)éthyle
- Propane, 1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)-
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 13 products.
Fluoromethyl 1,1,1,3,3,3-Hexafluoroisopropyl Ether
CAS:Formula:C4H3F7OPurity:>98.0%(GC)Color and Shape:Colorless to Almost colorless clear liquidMolecular weight:200.06Sevoflurane
CAS:Ethers of monohydric alcohols, nesoiFormula:C4H3F7OColor and Shape:Colorless Clear LiquidMolecular weight:200.00721Propane, 1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)-
CAS:Formula:C4H3F7OPurity:98%Color and Shape:LiquidMolecular weight:200.0548Sevoflurane
CAS:Formula:(CF3)2CHOCH2FPurity:≥ 99.5%Color and Shape:Clear, colourless liquidMolecular weight:200.06Fluoromethyl 2H-hexafluoroprop-2-yl ether
CAS:Fluoromethyl 2H-hexafluoroprop-2-yl etherFormula:C4H3F7OPurity:≥95%Color and Shape: clear. colourless liquidMolecular weight:200.05484g/molSevoflurane
CAS:<p>Sevoflurane (Fluoromethyl), a noncompetitive inhibitor of 5-HT3 receptor, acts as a low-soluble inhalation anesthetics.</p>Formula:C4H3F7OPurity:98%Color and Shape:Less Oil Colorless OilMolecular weight:200.051,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane
CAS:Controlled Product<p>Applications 1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane is an volatile anesthetic which inhibited activation of inflammatory neutrophil and granulocyte in human blood during simulated extracorporeal circulation.<br>References Schmid, E., et al.: Int. Immunopharmacol., 14, 202 (2012); Citerio, G., et al.: Euro. J. Anaesthesiol., 29, 371 (2012);<br></p>Formula:C4H3F7OColor and Shape:NeatMolecular weight:200.051,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane
CAS:Formula:C4H3F7OPurity:98%(GC);RGColor and Shape:Liquid, ClearMolecular weight:200.056Sevoflurane
CAS:Controlled Product<p>Sevoflurane is an experimental drug that belongs to the group of intravenous anaesthetics. It has been shown to be effective in the prevention and treatment of myocardial infarcts. Sevoflurane inhibits polymerase chain reaction by binding to dinucleotide phosphate, which prevents DNA synthesis. It also inhibits oxidative injury in the heart, as well as genotoxic activity. Sevoflurane is a potent chemical inhibitor of the ryanodine receptor, which regulates calcium release from the sarcoplasmic reticulum. This inhibition results in reduced contractility and relaxation of vascular smooth muscle cells, leading to vasodilation and increased blood flow.</p>Formula:C4H3F7OPurity:Min. 95%Color and Shape:Colorless PowderMolecular weight:200.05 g/mol












